GLOBE, GUARD Demos’ Approach To Licensed Drugs Alarms Small, Mid-Size Firms

The CMS policy could discourage ex-US licensing arrangements. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access